Toxic Neuropathies

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Toxic neuropathies most often present with symmetrical distal sensory loss, but sometimes affect exclusively motor or autonomic function, and very occasionally show features suggesting mononeuritis multiplex. Evidence of central nervous system dysfunction may also be present. The most common etiologic suspects are drugs, especially antineoplastic and antibacterial agents, organic solvents, organophosphorus compounds, and heavy metals. Obtaining a detailed medical and social history is crucial in arriving at the correct diagnosis. Electrophysiological studies are helpful in documenting the presence of neuropathy. In most instances, preventing continued exposure to the neurotoxic agent is sufficient to permit recovery, or at least to prevent further progression of clinical deficits.

Original languageEnglish (US)
Title of host publicationNeuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach
PublisherElsevier Inc.
Pages431-437
Number of pages7
ISBN (Print)9780124171275, 9780124170445
DOIs
StatePublished - Dec 3 2014

Fingerprint

Organophosphorus Compounds
Mononeuropathies
Poisons
Heavy Metals
Antineoplastic Agents
Central Nervous System
History
Anti-Bacterial Agents
Pharmaceutical Preparations

Keywords

  • Arsenic
  • Buckthorn
  • Chloroquine
  • Cisplatin
  • Colchicine
  • Hexane
  • Metronidazole
  • Nitrofurantoin
  • Organophosphates
  • Paclitaxel
  • Pyridoxine
  • Thalidomide
  • Thallium
  • Toxic neuropathy
  • Vincristine

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Pleasure, D. E. (2014). Toxic Neuropathies. In Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach (pp. 431-437). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-417044-5.00023-8

Toxic Neuropathies. / Pleasure, David E.

Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Elsevier Inc., 2014. p. 431-437.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pleasure, DE 2014, Toxic Neuropathies. in Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Elsevier Inc., pp. 431-437. https://doi.org/10.1016/B978-0-12-417044-5.00023-8
Pleasure DE. Toxic Neuropathies. In Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Elsevier Inc. 2014. p. 431-437 https://doi.org/10.1016/B978-0-12-417044-5.00023-8
Pleasure, David E. / Toxic Neuropathies. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach. Elsevier Inc., 2014. pp. 431-437
@inbook{f6ebdb371f1f4258a17fc8074f422b58,
title = "Toxic Neuropathies",
abstract = "Toxic neuropathies most often present with symmetrical distal sensory loss, but sometimes affect exclusively motor or autonomic function, and very occasionally show features suggesting mononeuritis multiplex. Evidence of central nervous system dysfunction may also be present. The most common etiologic suspects are drugs, especially antineoplastic and antibacterial agents, organic solvents, organophosphorus compounds, and heavy metals. Obtaining a detailed medical and social history is crucial in arriving at the correct diagnosis. Electrophysiological studies are helpful in documenting the presence of neuropathy. In most instances, preventing continued exposure to the neurotoxic agent is sufficient to permit recovery, or at least to prevent further progression of clinical deficits.",
keywords = "Arsenic, Buckthorn, Chloroquine, Cisplatin, Colchicine, Hexane, Metronidazole, Nitrofurantoin, Organophosphates, Paclitaxel, Pyridoxine, Thalidomide, Thallium, Toxic neuropathy, Vincristine",
author = "Pleasure, {David E}",
year = "2014",
month = "12",
day = "3",
doi = "10.1016/B978-0-12-417044-5.00023-8",
language = "English (US)",
isbn = "9780124171275",
pages = "431--437",
booktitle = "Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Toxic Neuropathies

AU - Pleasure, David E

PY - 2014/12/3

Y1 - 2014/12/3

N2 - Toxic neuropathies most often present with symmetrical distal sensory loss, but sometimes affect exclusively motor or autonomic function, and very occasionally show features suggesting mononeuritis multiplex. Evidence of central nervous system dysfunction may also be present. The most common etiologic suspects are drugs, especially antineoplastic and antibacterial agents, organic solvents, organophosphorus compounds, and heavy metals. Obtaining a detailed medical and social history is crucial in arriving at the correct diagnosis. Electrophysiological studies are helpful in documenting the presence of neuropathy. In most instances, preventing continued exposure to the neurotoxic agent is sufficient to permit recovery, or at least to prevent further progression of clinical deficits.

AB - Toxic neuropathies most often present with symmetrical distal sensory loss, but sometimes affect exclusively motor or autonomic function, and very occasionally show features suggesting mononeuritis multiplex. Evidence of central nervous system dysfunction may also be present. The most common etiologic suspects are drugs, especially antineoplastic and antibacterial agents, organic solvents, organophosphorus compounds, and heavy metals. Obtaining a detailed medical and social history is crucial in arriving at the correct diagnosis. Electrophysiological studies are helpful in documenting the presence of neuropathy. In most instances, preventing continued exposure to the neurotoxic agent is sufficient to permit recovery, or at least to prevent further progression of clinical deficits.

KW - Arsenic

KW - Buckthorn

KW - Chloroquine

KW - Cisplatin

KW - Colchicine

KW - Hexane

KW - Metronidazole

KW - Nitrofurantoin

KW - Organophosphates

KW - Paclitaxel

KW - Pyridoxine

KW - Thalidomide

KW - Thallium

KW - Toxic neuropathy

KW - Vincristine

UR - http://www.scopus.com/inward/record.url?scp=84944602715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944602715&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-417044-5.00023-8

DO - 10.1016/B978-0-12-417044-5.00023-8

M3 - Chapter

SN - 9780124171275

SN - 9780124170445

SP - 431

EP - 437

BT - Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach

PB - Elsevier Inc.

ER -